81216 BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis

Name of the Procedure:

BRCA2 (BRCA2, DNA repair associated) Gene Analysis; Full Sequence Analysis

Summary

This genetic test involves analyzing the full DNA sequence of the BRCA2 gene to identify mutations that could lead to an increased risk of hereditary breast and ovarian cancer. It helps determine whether an individual has inherited changes in the BRCA2 gene that may predispose them to certain types of cancer.

Purpose

The procedure addresses the need to identify genetic mutations that significantly raise the risk of developing hereditary breast and ovarian cancer. The expected outcome is to detect specific BRCA2 gene mutations, providing valuable information for cancer risk assessment, cancer prevention strategies, and potential treatment options.

Indications

• Family history of breast and/or ovarian cancer.
• Early-onset breast cancer (diagnosed before age 50).
• Multiple cases of breast cancer in the family, especially among close relatives.
• Male breast cancer in the patient or family.
• Personal or family history of multiple cancers (e.g., breast and ovarian).

Preparation

• No special preparation such as fasting is needed.
• Patients may be advised to bring a detailed family history.
• Genetic counseling is typically recommended before and after the test to help interpret the results and decide on further actions.

Procedure Description

1. Sample Collection: A blood sample is drawn from the patient.
2. DNA Extraction: DNA is extracted from the blood cells.
3. Sequencing: The BRCA2 gene is analyzed using advanced sequencing technologies to read the entire gene's DNA sequence.

4. Data Analysis: Bioinformatics tools and geneticists review the sequence data to identify any mutations.

   No anesthesia or sedation is necessary for this procedure.

Duration

The blood draw takes only a few minutes. However, the entire genetic analysis process, from sample collection to result interpretation, can take several weeks.

Setting

Typically performed in a clinical laboratory or genetic testing facility.

Personnel

• Phlebotomist or nurse for blood sample collection.
• Laboratory technicians and geneticists for DNA extraction and analysis.
• Genetic counselors for pre- and post-test consultations.

Risks and Complications

• Minimal risks from the blood draw, such as bruising or discomfort.
• Psychological impact from discovering genetic predispositions to cancer, which can be managed with proper counseling and support.

Benefits

• Identification of increased cancer risk due to BRCA2 mutations.
• Enables informed decision-making regarding cancer surveillance and preventive measures.
• Can guide personalized treatment plans if cancer is detected.

Recovery

• No recovery time is needed from the blood draw.
• Emotional and psychological support may be beneficial after receiving results.

Alternatives

• Single-site BRCA2 mutation testing if a known familial mutation is specified.
• BRCA1 gene analysis if relevant to the patient’s history.
• Comprehensive panel testing for multiple genes associated with hereditary cancers.

Each alternative offers different scopes of information and may vary in cost, complexity, and detection capability.

Patient Experience

• Blood sample collection is quick and typically only mildly uncomfortable.
• The waiting period for results can be a time of anxiety; thus, emotional support and counseling are crucial.
• Upon receiving results, patients will have the support of genetic counselors to understand and manage their health risks.